Oxaloacetate Energy Supplement: Bioavailability Tested Once, Never Again

The Oasis Health Journal · Submitted September 25, 2026 · 10:01 AM EDT

By Marlo Quist · Edited by Priya Raman, C.N.C.

Oxaloacetate is a four-carbon molecule that sits at the center of the Krebs cycle. The Krebs cycle is how mitochondria make ATP. ATP is cellular energy.

Someone looked at that and thought, we should sell the middle part.

That is how you get an oxaloacetate energy supplement. You take a thing that is already happening and charge forty dollars for it.

Your Stomach Does Not Care About The Krebs Cycle

The Krebs cycle is real. It happens in your mitochondria. Oxaloacetate enters, binds with acetyl-CoA, forms citrate, and the whole thing spins around making NADH and FADH2. Those feed the electron transport chain. The chain pumps protons. The protons make ATP.

That is energy metabolism. It is elegant. It does not need pills.

Oxaloacetate is not stable in stomach acid. It degrades. The molecule you swallow is not the molecule reaching your mitochondria. That is if anything reaches your mitochondria at all. This is a known problem with Krebs cycle supplements. You are mailing a letter to an address that does not exist.

In 2013, researchers gave twelve people 100 mg of oral oxaloacetate and measured their blood for eight hours. They detected oxaloacetate. They saw increases in downstream metabolites. The study said oral oxaloacetate can be absorbed.

Twelve people. One dose. No control group. No measurement of energy.

Nobody has repeated the study. That was thirteen years ago.

What The Research Measured (It Was Not Tired People Feeling Better)

A 2026 review in Biological Psychiatry Global Open Science tracked TCA cycle intermediates in 102 patients getting electroconvulsive therapy for depression. Levels of citrate and pyruvate changed at three time points. The paper said that suggests ECT modulates mitochondrial function.

That is observational data from a medical procedure. It is not an oxaloacetate energy supplement telling you to feel awake.

A 2026 study in the European Journal of Applied Physiology gave fifty-four men either 300 mg of ubiquinol or placebo for six weeks. Ubiquinol is the reduced form of CoQ10. It is another mitochondrial thing people sell. Plasma CoQ10 went up. Oxidative phosphorylation coupling efficiency improved in muscle tissue.

Exercise time to exhaustion did not improve. Oxygen uptake kinetics did not improve.

The mitochondria got more efficient. The men did not get faster. That is the whole problem with this field in one sentence.

A 2026 paper in Biochemical Pharmacology discussed precision metabolic therapy for propionic acidemia. That is a genetic disorder that breaks TCA cycle flux. Researchers proposed restoring the balance between propionyl-CoA and acetyl-CoA while replenishing CoA pools through acetate supplementation and NRF2 activation.

That is rational combination therapy for a specific disease. It is not instructions for someone who slept badly and drank too much coffee.

The Bioavailability Problem Everyone Pretends Is Solved

Oral bioavailability is the fraction of a dose that reaches your blood unchanged. For most mitochondrial energy boosters, that fraction is embarrassing.

Oxaloacetate degrades in the stomach. CoQ10 is fat-soluble and does not absorb well unless you eat it with butter. NAD+ precursors get broken down in the gut. Some nicotinamide riboside makes it through. Some does not.

The 2013 study detected oxaloacetate in blood. That means some survived the trip. The study did not compare oral dosing to intravenous dosing, so we do not know how much was lost. We do not know if the amount that got through does anything inside a mitochondrion. We do not know if taking it daily for six weeks would change the outcome.

We know it appeared in twelve blood samples. That is the bar.

The supplement sells in 100 mg capsules. Standard dose is one or two per day. Prices run from thirty-five cents to a dollar per capsule. The good brands tell you where they source it and how they stabilize it. The cheap brands do not tell you anything, which is honest in its own way.

Your Krebs Cycle Is Not Broken

Your mitochondria already make oxaloacetate. The Krebs cycle is a closed loop. Oxaloacetate gets regenerated at the end of each turn. If the cycle slows down, it is because something upstream broke. Not enough acetyl-CoA. Insufficient CoA. An enzyme got inhibited. The electron transport chain backed everything up.

It is not an oxaloacetate shortage.

A 2026 paper in the World Journal of Critical Care Medicine proposed that sepsis starts with mitochondrial redox disturbance. Excess hydrogen peroxide inhibits aconitase, a Krebs cycle enzyme. That impairs NADH and FADH2 generation. The proton motive force dissipates. ATP collapses.

In that scenario, the problem is not missing oxaloacetate. The problem is a blocked enzyme. Adding more oxaloacetate does not unblock it. That is like mailing more letters when the mailbox is on fire.

In healthy people, Krebs cycle flux is regulated by substrate availability, enzyme activity, and feedback from ATP and NADH. The cycle does not run out of intermediates. If you feel tired, the issue is sleep. Or iron. Or thyroid function. Or the fact that you have been awake since six in the morning and it is now nine at night.

It is not an oxaloacetate deficiency. Your body has never heard of an oxaloacetate deficiency.

The One Study That Does Not Prove What You Think It Proves

The evidence base for oral oxaloacetate energy supplement use is one twelve-person pharmacokinetic study from 2013. The study was not designed to measure energy. It measured whether oxaloacetate could be detected in blood after someone swallowed it.

It could. That is the whole foundation.

No follow-up trial compared oxaloacetate to placebo in healthy adults with fatigue as an endpoint. No trial measured ATP synthesis rates. No trial measured muscle performance or cognitive function. No trial dosed people for twelve weeks and asked if they felt different.

The mechanism is plausible. The Krebs cycle is real. Oxaloacetate is in it. But plausibility is not evidence. Detection in blood is not proof of anything except detection in blood.

You are paying forty to seventy dollars for a sixty-day supply of a molecule your body already makes, based on one small study that did not measure the thing you want.

That is the business model. It is a good one. Just not for you.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Dissipation of the mitochondrial proton motive force drives sepsis pathogenesis and explains hyperlactatemia's predictive value in sepsis mortality, World journal of critical care medicine (2026).
2. Spatiotemporal iron-hijacking hydrogel reprograms host-pathogen iron homeostasis for fungal keratitis therapy, Cell reports. Medicine (2026).
3. Precision metabolic therapy for propionic acidemia, Biochemical pharmacology (2026).
4. Electroconvulsive Treatment for Depression Alters Mitochondrial Serum Metabolites, Biological psychiatry global open science (2026).
5. Effect of six weeks ubiquinol supplementation on mitochondrial respiratory function and exercise capacity in healthy males, European journal of applied physiology (2026).